Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.2.9805.0488
Address
Level 2 66 Hunter Street North Ryde, New South Wales (NSW) 2000
Description
Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. It is developing the compound BIT225 for the treatment of HIV-1. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.06
Trade Value (12mth)
AU$7,190.00
1 week
0%
1 month
0%
YTD
-80.95%
1 year
-94.96%
All time high
0.38
EPS 3 yr Growth
-15.40%
EBITDA Margin
N/A
Operating Cashflow
-$4m
Free Cash Flow Return
-243.10%
ROIC
-234.20%
Interest Coverage
-4,706.00
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
1134m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
24 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
10 April 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
08 April 25 |
Rights Issue Closed
×
Rights Issue Closed |
08 April 25 |
Application for quotation of securities - BIT
×
Application for quotation of securities - BIT |
18 March 25 |
Dispatch of Rights Issue Offer documents
×
Dispatch of Rights Issue Offer documents |
18 March 25 |
Biotron Limited - Dispatch of Rights Issue Offer documents (BIT-AU)
×
Biotron Limited - Dispatch of Rights Issue Offer documents (BIT-AU) |
13 March 25 |
Update - Proposed issue of securities - BIT
×
Update - Proposed issue of securities - BIT |
13 March 25 |
Update on Rights Issue Timetable
×
Update on Rights Issue Timetable |
13 March 25 |
Biotron Limited - Update - Proposed issue of securities - BIT (BIT-AU)
×
Biotron Limited - Update - Proposed issue of securities - BIT (BIT-AU) |
13 March 25 |
Biotron Limited - Update on Rights Issue Timetable (BIT-AU)
×
Biotron Limited - Update on Rights Issue Timetable (BIT-AU) |
12 March 25 |
Response to ASX Query Letter
×
Response to ASX Query Letter |
12 March 25 |
Replacement Prospectus
×
Replacement Prospectus |
12 March 25 |
Biotron Limited - Response to ASX Query Letter (BIT-AU)
×
Biotron Limited - Response to ASX Query Letter (BIT-AU) |
12 March 25 |
Biotron Limited - Replacement Prospectus (BIT-AU)
×
Biotron Limited - Replacement Prospectus (BIT-AU) |
10 March 25 |
Delay in Offer Opening - BITR
×
Delay in Offer Opening - BITR |
10 March 25 |
Update - Proposed issue of securities - BIT
×
Update - Proposed issue of securities - BIT |
10 March 25 |
Biotron Limited - Delay in Offer Opening - BITR (BIT-AU)
×
Biotron Limited - Delay in Offer Opening - BITR (BIT-AU) |
10 March 25 |
Biotron Limited - Update - Proposed issue of securities - BIT (BIT-AU)
×
Biotron Limited - Update - Proposed issue of securities - BIT (BIT-AU) |
05 March 25 |
Commencement of Rights Trading
×
Commencement of Rights Trading |
05 March 25 |
Supplementary Prospectus
×
Supplementary Prospectus |
05 March 25 |
Update - Proposed issue of securities - BIT
×
Update - Proposed issue of securities - BIT |
04 March 25 |
Response to ASX Aware Query
×
Response to ASX Aware Query |
03 March 25 |
Prospectus
×
Prospectus |
28 February 25 |
Renounceable Rights Issue
×
Renounceable Rights Issue |
28 February 25 |
Proposed issue of securities - BIT
×
Proposed issue of securities - BIT |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.